SCHEMBL8055544

SCHEMBL8055544

CCc1cccc(CNc2ccc(Cl)nn2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
RECQL P46063 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
VNN1 O95497 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
KCNN3 Q9UGI6 2/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3971763 0.81 MAPT (0.50) MAPTNPC1RAB9ARECQLMEN1
SCHEMBL22190875 0.80 MAPT (0.64) MAPTNPC1RAB9ARECQLMEN1
SCHEMBL8051447 0.74 MAPT (0.42) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL12895544 0.73 MAPT (0.54) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL18904116 0.72 ALDH1A1 (0.41) NPC1MEN1KMT2AKDM4ELMNA
SCHEMBL22191121 0.71 ALDH1A1 (0.49) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27401621 0.70 MAPT (0.50) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL6756121 0.69 RAPGEF4 (0.44) MAPTLMNAALDH1A1CYP1A2TSHR
SCHEMBL16110725 0.68 ALDH1A1 (0.51) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL166894 0.67 TP53 (0.61) MAPTNPC1RAB9ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009050227-A1 PYRIDAZINE DERIVATIVES FOR INHIBITING BETA AMYLOID PEPTIDE PRODUCTION GLAXO GROUP LIMITED (GB) 2009-04-23 WO disclosed